The drug shortage program, within the Center for Drug Evaluation and Research (CDER), addresses potential or actual shortages of prescription, over-the-counter, or generic drugs that have a significant impact on public health. http://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm en-us Thu, 13 Sep 2012 11:20 EDT cderwebmaster@fda.hhs.gov Updated list of current drug shortages. Thu, 13 Sep 2012 11:20 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm Updated list of current drug shortages. Tue, 11 Sep 2012 13:00 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm Updated list of current drug shortages. Thu, 06 Sep 2012 13:40 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm See the new and updated list of current drug shortages. Tue, 28 Aug 2012 08:52 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm See the updated list of current drug shortages. Fri, 24 Aug 2012 12:43 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm See the updated list of current drug shortages. Wed, 23 Aug 2012 11:45 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm See the updated list of current drug shortages. Mon, 20 Aug 2012 08:37 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm See the web page list of current drug shortage updates Thu, 16 Aug 2012 15:04 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm Sagent 10 mg/mL, 10 mL multi-dose vial (NDC 25021-672-10), On allocation. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#atracurium Hospira: 50,000 units/mL, 2 mL vial (NDC 61703-418-07), Next delivery TBD. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#aquasol Hospira: 100 mg/mL; 30 mL vial (NDC 0409-3307-03), Next delivery October. 200 mg/mL; 30 mL vial (NDC 0409-3308-03), Next delivery November. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#acetylcysteine Hospira: Company estimates a release date by 1Q 2013. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#bumetanide Teva supply is adequate to meet demand. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#amphetamine Hospira: 0.25mg/mL; 4mL (NDC 00409-1412-04), Next delivery September. 0.25mg/mL; 10mL vial (NDC 00074-1412-10), Next delivery September. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#bumetanide Hospira: 0.25%; 10 mL vial (NDC 0409-1159-01) and 0.25%; 30 mL vial (NDC 0409-1159-02), Next delivery August. 0.75%; 10 mL vial (NDC 0409-1165-01), and 0.75%; 30 mL vial (NDC 0409-1165-02) Next delivery October. 0.75% in Dex 8.25%; 2mL amp (NDC 0409-3613-01), Next delivery August. 0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01) Next delivery September. 0.5% w/epi 1:200,000; 30 mL vial (NDC 0409-9045-17) Ample levels available to meet market demand. 0.5% w/epi 1:200,000; 50 mL vial (NDC 0409-9046-01) Next delivery July. 50 mg/20 mL Sterile pack amp (NDC 0409-4272-01), Next delivery September. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#bupivacaine Hospira: 1 mg/mL; 1 mL vial (NDC 0409-1623-01), Next delivery October. 2 mg/mL; 1 mL vial (NDC 0409-1626-01), Next delivery August. 2 mg/mL; 2 mL vial, (NDC 0409-1626-02) Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#butorphanol Hospira: Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#desmopressin Teva, available. Inventory will remain low until 4Q12. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#dextroamphetamine Hospira: Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314739.htm#diazepam Hospira: Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#epinephrine Hospira: Next delivery October. Mylan, next shipment September 2012. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#etomidate Hospira: 0.05 mg/mL; 2 mL vial (0409-9094-22) Next delivery September. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#fentanyl Hospira: 10 mg/mL; 2mL vial (NDC 0409-6102-02, Next delivery September. 10 mg/mL; 4mL vial (NDC 0409-6102-04), Regular deliveries with intermittent backorders; next delivery August. 10 mg/mL;10mL vial (NDC 0409-6102-10), Next delivery September. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#furosemide Hospira: 1 mg/mL; 1 mL amp (NDC 0409-2552-01), Next delivery August. 2 mg/mL; 1 mL vial (NDC 0409-3365-01), Next delivery October. 4mg/mL; 1mL Carpuject, (NDC 0409-1304-31) Next delivery August. 2mg/mL; 1mL Carpuject (NDC 0409-1312-30), Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#hydromorphone Check web page for updated. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314740.htm#isoniazid Teva: All presentation are available with ample inventory. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#methotrexate Teva: 50 mg, 100 count (NDC 00093-7178-01) and 150 mg, 60 count (NDC 00093-7113-06), Available. Inventory will remain low until 4Q12. 100 mg, 60 count (NDC 00093-1024-06), Available. Teva supply adequate to meet demand. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#nefazodone Next delivery July. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#lidocaine Hospira: 2 mg/mL; 1 mL vial (NDC 00409-6778-02), Next delivery October. 2 mg/mL; 10 mL vial (NDC 0409-6780-02), Next delivery October. 2 mg/mL; 1 mL Carpuject syringe (NDC 0409-1985-30), Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#lorazepam Hospira: 50%; 20 mL vial (NDC 0409-2168-02), Next delivery March 2013. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#magnesium Hospira: 1 mg/mL, 30 mL PCA vial (NDC 0409-2029-02), Hospira is providing through direct customers only. Next delivery August. 2 mg/mL; 1 mL Carpuject (NDC 0409-1762-30), Next delivery August. 4 mg/mL; 1 mL Carpuject (NDC 0409-1258-30), Next delivery August. 8 mg/mL; 1 mL Carpuject (NDC 0409-1260-69) Next delivery November. 15 mg/mL; 1 mL Carpuject syringes (NDC 0409-1264-31), Next delivery December. 50 mg/mL, 20 mL vial (NDC 0409-1134-03) Ample levels of inventory to meet market demand. 25 mg/mL; 4 mL Add-vantage vial (NDC 0409-6177-14), Next delivery October. 25 mg/mL, 10 mL Add-Vantage vial (NDC 0409-6179-14), Next delivery October. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#methotrexate Hospira: 1 mg/mL, 30 mL PCA vial (NDC 0409-2029-02), Hospira is providing through direct customers only. Next delivery August. 2 mg/mL; 1 mL Carpuject (NDC 0409-1762-30), Next delivery August. 4 mg/mL; 1 mL Carpuject (NDC 0409-1258-30), Next delivery August. 8 mg/mL; 1 mL Carpuject (NDC 0409-1260-69) Next delivery November. 15 mg/mL; 1 mL Carpuject syringes (NDC 0409-1264-31), Next delivery December. 50 mg/mL, 20 mL vial (NDC 0409-1134-03) Ample levels of inventory to meet market demand. 25 mg/mL; 4 mL Add-vantage vial (NDC 0409-6177-14), Next delivery October. 25 mg/mL, 10 mL Add-Vantage vial (NDC 0409-6179-14), Next delivery October. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#morphinesulfate Naloxone 0.4 mg/mL Injection; 1mL vial (NDC 00409-1215-01), Next delivery September. Naloxone 0.4 mg/mL Injection; 10mL MDV (NDC 00409-1219-01), Next delivery October. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314741.htm#naloxone Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314742.htm#ondansetron Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314742.htm#pentostatin Hospira: 2 mEq/mL; 15 mL vial (NDC 0409-6636-01), Next delivery January. 2 mEq/mL; 10 mL vial (NDC 0409-6651-06), Next delivery August. 2 mEq/mL; 20 mL vial (NDC 0409-6653-05), Next delivery August. 20 mEq/1000mL in 5% Dex/Lact Ringers Next delivery August. 20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 00409-7107-09) Ample levels of inventory to meet market demand. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314742.htm#pchloride Hospira: 500 mg/mL; 2 mL vial (NDC 0409-1903-01), Next delivery November. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314742.htm#procainamide Hospira: Next delivery TBD. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314742.htm#propofol Hospira: 2 mEq/mL; 20 mL vial (NDC 0409-7299-73), Next delivery August. 2 mEq/mL; 50 mL vial (NDC 0409-3299-05), Ample levels of inventory available to meet market demand. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314743.htm#sodiuma Hospira: 1 mEq/mL; 50 mL vial (NDC 0409-6625-02), Next delivery August. 1 mEq/mL; 50 mL Abboject (NDC 0409-6637-34), Next delivery August and 1 mEq/mL; 10 mL Abboject (NDC 0409-4900-34) Next delivery August. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314743.htm#sodiumb Available. Teva supply adequate to meet demand. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314743.htm#ticlopidine Available with ample inventory. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314743.htm#viaspan American Regent is currently unavailable. Tue, 14 Aug 2012 13:09 EDT http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm314743.htm#zinc